Revolutionizing the Industry: AcreTrader Earns Spot on Fast Company’s Prestigious List of Most Innovative Companies for 2023

Land Investment and Technology Company Joins the Ranks of Top Innovators AcreTrader Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2023 Fayetteville, Ark., March 02, 2023 (GLOBE NEWSWIRE) — AcreTrader has been named to Fast Company’s prestigious annual list of the World’s Most Innovative Companies for 2023. This recognition solidifies…

Read More

European Patent for RencoFilStat: A Major Boost to Hepion’s Patent Portfolio

Hepion Pharmaceuticals Receives European Patent for Rencofilstat Patent Covers 38 European Countries Rencofilstat’s Exclusivity May Extend into 2048 EDISON, N.J., March 02, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), fibrotic diseases, hepatocellular carcinoma (“HCC”),…

Read More

Discover the Best Ransomware Protection for 2023: PC Magazine Ranks Data443’s Ransomware Recovery Manager at the Top!

PC Magazine Selects Data443’s Ransomware Recovery Manager as One of the Best Ransomware Protections In a recent announcement, Data443 Risk Mitigation, Inc. revealed that PC Magazine has recognized their Ransomware Recovery Manager (RRM) as one of the top ransomware protection solutions in the market. The software was awarded the titles of “Best of Inexpensive Protection”…

Read More

FDA Accepts Biologics License Application for Cosibelimab in Skin Cancer: Checkpoint Therapeutics Makes Major Strides

Checkpoint Therapeutics Announces FDA Filing Acceptance of Biologics License Application for Cosibelimab in Metastatic Understanding the Prescription Drug User Fee Act (“PDUFA”) Goal Date On January 3, 2024, the Prescription Drug User Fee Act (“PDUFA”) goal date for Cosibelimab in Metastatic will mark a significant milestone for Checkpoint Therapeutics, Inc. The FDA has indicated that…

Read More

Revving Up: Driver Assistance System Market Set to Reach $73 Billion by 2030, According to Market Research Future (MRFR) Report

Increasing Interest towards Vehicle Automation to Drive the Driver Assistance System Market New York, US, March 02, 2023 (GLOBE NEWSWIRE) — Market Research Future (MRFR) Report Overview: According to a detailed research report by Market Research Future (MRFR), the Driver Assistance System Market is expected to witness significant growth in the coming years. The report…

Read More

Deutsche Börse’s Cash Markets See 35% Drop in Turnover, But Show Slight Improvement in February

Deutsche Börse’s cash markets turnover drops 35% YoY but strengthens slightly on monthly basis in February Trading volumes on Börse Frankfurt In February 2023 came in at €2.93 billion, down from €3.01 billion in January 2023. Equities on Deutsche Börse generated € 96.93 billion last month, while trading in ETFs/ETCs/ETNs accounted for €14.84 billion of…

Read More

Option Care Health: A Heartfelt Announcement of Secondary Offering and Common Stock Repurchase

Option Care Health Announces Pricing of Secondary Offering of 13,000,000 Shares of Common Stock and Common Stock Repurchase BANNOCKBURN, Ill., March 01, 2023 (GLOBE NEWSWIRE) — Option Care Health, Inc. (“Option Care Health” or the “Company”) (NASDAQ: OPCH) announced today that an affiliate of Walgreens Boots Alliance, Inc. (the “Selling Stockholder”) has agreed to sell…

Read More